Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$1.22 USD
+0.02 (1.67%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.21 -0.01 (-0.82%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
CLOV 1.22 +0.02(1.67%)
Will CLOV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLOV
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
Enovis (ENOV) Q1 Earnings Match Estimates
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
3 Medical Info Systems Stocks to Buy as Industry Rebounds
Clover Health Investments, Corp. (CLOV) Upgraded to Buy: Here's Why
Other News for CLOV
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
Clover Health regains compliance with Nasdaq minimum bid price requirement
Clover Health regains compliance with Nasdaq
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
What's Driving Alignment Healthcare Inc's Surprising 49% Stock Rally?